![]() |
|
|
Molecular Pharmacology, Vol 5, 428-431, Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics
1 Ben May Laboratory for Cancer Research and Department of Biochemistry,
University of Chicago, Chicago, Illinois 6O637
Cyproterone (1,2
-methylene-6-chloro-
4,6-pregnadien-17
-ol-3,20-dione) 17
-acetate, a
potent anti-androgen, suppressed the uptake of radioactive androgens in vivo by the ventral
prostate of rats. This was accompanied by a decrease in the retention of 5
-dihydrotestosterone (17
-hydroxy-5
-androstan-3-one) by prostate cell nuclei . Cyproterone and its
17
-acetate (less than 0.5 µg/ml) also inhibited the formation of a specific dihydrotestosterone-protein complex in prostate cell nuclei when minced prostate was incubated with
radioactive testosterone or dihydrotestosterone. Estradiol-17
, diethylstilbestrol, and
progesterone, but not hydrocortisone succinate, also suppressed the retention of dihydrotestosterone by prostatic cell nuclei in vitro, but to a much lesser extent than cyproterone.
Note:
ACKNOWLEDGMENTS
The authors wish to express their appreciation
to Mrs. A. H. Lin, Mrs. D. Sagher, and Mr. J.
L. Tymoczko for their skillful technical assistance.
This article has been cited by other articles:
![]() |
J. A. Kemppainen, E. Langley, C.-i. Wong, K. Bobseine, W. R. Kelce, and E. M. Wilson Distinguishing Androgen Receptor Agonists and Antagonists: Distinct Mechanisms of Activation by Medroxyprogesterone Acetate and Dihydrotestosterone Mol. Endocrinol., March 1, 1999; 13(3): 440 - 454. [Abstract] [Full Text] |
||||